Attached files
| file | filename |
|---|---|
| EX-31.2 - EXHIBIT 31.2 - Kindred Biosciences, Inc. | exhibit312-201710k.htm |
| EX-31.1 - EXHIBIT 31.1 - Kindred Biosciences, Inc. | exhibit311-201710k.htm |
| EX-23.1 - EXHIBIT 23.1 - Kindred Biosciences, Inc. | exhibit231-201710k.htm |
| EX-21.1 - EXHIBIT 21.1 - Kindred Biosciences, Inc. | exhibit211listofsubsidaries.htm |
| EX-10.21 - EXHIBIT 10.21 - Kindred Biosciences, Inc. | exhibit1019-secondleaseadd.htm |
| EX-10.20 - EXHIBIT 10.20 - Kindred Biosciences, Inc. | exhbit1018-officeleaseadde.htm |
| EX-10.8 - EXHIBIT 10.8 - Kindred Biosciences, Inc. | exhibit108-2016equityincen.htm |
| 10-K - 10-K - Kindred Biosciences, Inc. | kindredbio201710-k.htm |
Exhibit 32.1
CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER
Pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Kindred Biosciences, Inc. (the “Company”) hereby certifies that, to his knowledge:
(i) The Annual Report on Form 10-K of the Company for the fiscal year ended December 31, 2017 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
(ii) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: March 1, 2018 | By: /s/ Richard Chin | |
Name: Richard Chin, M.D. | ||
Title: Chief Executive Officer | ||
CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER
Pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Kindred Biosciences, Inc. (the “Company”) hereby certifies that, to his knowledge:
(i) The Annual Report on Form 10-K of the Company for the fiscal year ended December 31, 2017 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
(ii) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: March 1, 2018 | By: /s/ Wendy Wee | |
Name: Wendy Wee | ||
Title: Chief Financial Officer | ||